Utilidad del Score PI-RADS 2 en la Práctica Clínica ¿Se Justifica el estudio histológico?

Abstract

Objective: To evaluate the results of histological studies and if these are justified in patients categorized as PI-RADS 2. Materials and methods: A search was made in the PACS of our institution, of all prostate MRI reports that included category “PI-RADS 2” between january 2015 and june 2017, identifying 1287 reports. Results: of the 1287 PI-RADS 2 reports, 646 patients were monitored after the MRI in our institution. of these, 91 (14.08%) had an histological study. We found 10 cases (10.98%) of prostate cancer (6 with Gleason score 6, and 4 with Gleason score 7). Conclusion: In our study, the MR PI-RADS 2 score correctly ruled out clinically significant neoplasia in 95.6% of cases. Making this information known could have an impact on the doctor’s course of action, decreasing the number of prostate biopsies.